Tools and resources
for prescribers

WELLBUTRIN XL PRIOR AUTHORIZATION (PA) PROCESS BROCHURE

Cover of Wellbutrin XL Prior Authorization Guide, featuring a hand typing on a laptop keyboard, with guide details and safety information below.

Cover of Wellbutrin XL Prior Authorization Guide, featuring a hand typing on a laptop keyboard, with guide details and safety information below.

Review this guide to help navigate prescription coverage requirements.

Sample Letter of Medical Necessity

Sample letter of medical necessity template, including fields for patient information, diagnosis, and treatment justification, formatted with placeholders for customization.

Sample letter of medical necessity template, including fields for patient information, diagnosis, and treatment justification, formatted with placeholders for customization.

Use this sample letter for payers who may require a Letter of Medical Necessity to process and cover claims.

Sample Medical Exception Request

Medicare Part D Coverage Determination Request Form, with sections for patient and prescriber information, diagnosis, medication details, and rationale for prior authorization.

Medicare Part D Coverage Determination Request Form, with sections for patient and prescriber information, diagnosis, medication details, and rationale for prior authorization.

Use this sample letter to request a medical exception for your patient.

Sample Medical Appeal Letter

Sample letter of medical necessity template, including fields for patient information, diagnosis, and treatment justification, formatted with placeholders for customization.

Sample letter of medical necessity template, including fields for patient information, diagnosis, and treatment justification, formatted with placeholders for customization.

Use this sample letter to request an appeal of a coverage decision.

In adults, treatment of MDD and prevention of seasonal major depressive episodes in patients with a diagnosis of SAD1.

INDICATION

WELLBUTRIN XL® (bupropion hydrochloride) extended-release tablets is indicated for the treatment of major depressive disorder (MDD), and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.

IMPORTANT SAFETY INFORMATION AND INDICATION

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

SUICIDALITY AND ANTIDEPRESSANT DRUGS:

Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in subjects aged 65 and older.

In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.

INDICATION

WELLBUTRIN XL® (bupropion hydrochloride) extended-release tablets is indicated for the treatment of major depressive disorder (MDD), and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.

IMPORTANT SAFETY INFORMATION AND INDICATION

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

SUICIDALITY AND ANTIDEPRESSANT DRUGS:

Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in subjects aged 65 and older.

In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.